Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Annals of hematology [Ann Hematol] NLMUID: 9107334"" wg kryterium: JN


Tytuł :
Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone.
Autorzy :
Cai QQ; Department of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, 315040, Zhejiang, China.
Gao XM; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Le J; Department of Hematology, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, 315040, Zhejiang, China.
Zhao H; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Cai H; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Cao XX; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr 10. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Education of early palliative care specialists among hematologists and oncologists to address patients' rather than physicians' rights.
Autorzy :
Potenza L; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Luppi M; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy. .
Borelli E; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Bigi S; Department of Linguistic Sciences and Foreign Literatures, Catholic University of the Sacred Heart, Milan, Italy.
Bandieri E; Oncology and Palliative Care Units, Civil Hospital Carpi, USL, Carpi, Italy.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr 10. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique.
Autorzy :
Owattanapanich W; Department of Internal Medicine III, University Hospital of Ulm, 89081, Ulm, Germany.; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Herzig J; Department of Internal Medicine III, University Hospital of Ulm, 89081, Ulm, Germany.
Jahn N; Department of Internal Medicine III, University Hospital of Ulm, 89081, Ulm, Germany.
Panina E; Department of Internal Medicine III, University Hospital of Ulm, 89081, Ulm, Germany.
Ruchutrakool T; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Kungwankiattichai S; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Issaragrisil S; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Döhner H; Department of Internal Medicine III, University Hospital of Ulm, 89081, Ulm, Germany. .
Döhner K; Department of Internal Medicine III, University Hospital of Ulm, 89081, Ulm, Germany. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr 10. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A Filipino infant with severe neutropenia owing to SRP54 mutations was successfully treated with ethnically mismatched cord blood transplantation from a Japanese cord blood bank.
Autorzy :
Tamura T; Department of Pediatrics and Child Health, Nihon University Itabashi Hospital, 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan.
Yagasaki H; Department of Pediatrics and Child Health, Nihon University Itabashi Hospital, 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan. .
Nakahara E; Department of Pediatrics and Child Health, Nihon University Itabashi Hospital, 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan.
Ito M; Department of Pediatrics and Child Health, Nihon University Itabashi Hospital, 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan.
Ueno M; Department of Pediatrics and Child Health, Nihon University Itabashi Hospital, 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan.
Kanezawa K; Department of Pediatrics and Child Health, Nihon University Itabashi Hospital, 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan.
Hirai M; Department of Pediatrics and Child Health, Nihon University Itabashi Hospital, 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan.
Morioka I; Department of Pediatrics and Child Health, Nihon University Itabashi Hospital, 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr 10. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Stanozolol for the treatment of anemic lower-risk myelodysplastic syndromes without del(5q) after failure of epoetin alfa: findings from a retrospective study.
Autorzy :
Qu WY; Department of Hematology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai, 200120, China.
Zhao L; Department of Hematology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai, 200120, China. .
Tan XC; Department of Hematology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai, 200120, China.
Zhao YH; Department of Hematology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai, 200120, China.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr 10. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
δ-Hemoglobinopathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia.
Autorzy :
Singha K; Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand.; Faculty of Medicine, Mahasarakham University, Mahasarakham, Thailand.
Fucharoen G; Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand.
Fucharoen S; Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr 08. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Allogeneic stem cell transplantation for mantle cell lymphoma-update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74).
Autorzy :
Krüger WH; Department of Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation, Palliative Care - University of Greifswald, Ferdinand-Sauerbruch-Straße, 17475, Greifswald, Germany. .
Hirt C; Department of Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation, Palliative Care - University of Greifswald, Ferdinand-Sauerbruch-Straße, 17475, Greifswald, Germany.
Basara N; Department Haematology/Oncology, University Hospital Leipzig, Leipzig, Germany.
Sayer HG; Department for Haematology and Oncology, Clinic for Internal Medicine II, University Hospital Jena, Jena, Germany.
Behre G; Department Haematology/Oncology, Martin Luther University, Halle/S, Germany.
Fischer T; Department Haematology/Oncology, Otto von Guericke University, Magdeburg, Germany.
Grobe N; Dietrich Bonhoeffer Hospital, Neubrandenburg, Germany.
Maschmeyer G; Hospital Ernst von Bergmann, Potsdam, Germany.
Neumann T; Department of Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation, Palliative Care - University of Greifswald, Ferdinand-Sauerbruch-Straße, 17475, Greifswald, Germany.
Schneidewind L; Department of Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation, Palliative Care - University of Greifswald, Ferdinand-Sauerbruch-Straße, 17475, Greifswald, Germany.
Niederwieser D; Department Haematology/Oncology, University Hospital Leipzig, Leipzig, Germany.
Dölken G; Department of Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation, Palliative Care - University of Greifswald, Ferdinand-Sauerbruch-Straße, 17475, Greifswald, Germany.
Schmidt CA; Department of Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation, Palliative Care - University of Greifswald, Ferdinand-Sauerbruch-Straße, 17475, Greifswald, Germany.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr 08. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
Autorzy :
Qian Y; Department of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan Province, China.
Chen Y; Department of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan Province, China.
Li X; Department of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan Province, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr 06. Date of Electronic Publication: 2021 Apr 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.
Autorzy :
Bhurani D; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, Delhi, 110085, India. .
Kapoor J; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, Delhi, 110085, India.
Yadav N; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, Delhi, 110085, India.
Khushoo V; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, Delhi, 110085, India.
Agrawal N; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, Delhi, 110085, India.
Ahmed R; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, Delhi, 110085, India.
Arora JS; National Thalassemia Welfare Society, Delhi, 110018, India.
Mehta P; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, Delhi, 110085, India.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr 03. Date of Electronic Publication: 2021 Apr 03.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Circulating low CD4 ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients.
Autorzy :
Cao X; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, 226000, China.
Kong YL; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
Wang L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
Liang JH; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
Xia Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
Zhu HY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
Fan L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
Jiang SH; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, 226000, China.
Liu H; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, 226000, China.
Li JY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China.
Xu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China. .; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China. .; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 210029, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 995-1002. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
CD4-CD8 Ratio*
Waldenstrom Macroglobulinemia/*blood
Adult ; Aged ; Aged, 80 and over ; Antimetabolites, Antineoplastic/administration & dosage ; Antineoplastic Agents, Alkylating/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bortezomib/administration & dosage ; Dexamethasone/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Prognosis ; Progression-Free Survival ; Retrospective Studies ; Rituximab/administration & dosage ; Survival Rate ; Treatment Outcome ; Waldenstrom Macroglobulinemia/drug therapy ; Waldenstrom Macroglobulinemia/genetics ; Waldenstrom Macroglobulinemia/mortality ; beta 2-Microglobulin/analysis
Czasopismo naukowe
Tytuł :
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
Autorzy :
Russell J; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Collins A; Department of Haematology, Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney Lane, Norwich, NR4 7UY, UK.
Fowler A; Department of Haematology, Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Edith Cavell Campus, Bretton Gate, Peterborough, PE3 9G, UK.
Karanth M; Department of Haematology, West Suffolk Hospital, West Suffolk NHS Trust, Hardwick Lane, Bury St Edmunds, IP33 2QZ, UK.
Saha C; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Docherty S; Department of Haematology, Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney Lane, Norwich, NR4 7UY, UK.
Padayatty J; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Maw K; Department of Haematology, James Paget University Hospital, James Paget University Hospitals NHS Foundation Trust, Lowestoft Road, Gorleston-on-Sea, Great Yarmouth, NR31 6LA, UK.
Lentell I; Department of Haematology, West Suffolk Hospital, West Suffolk NHS Trust, Hardwick Lane, Bury St Edmunds, IP33 2QZ, UK.
Cooke L; Department of Haematology, The Queen Elizabeth Hospital, King's Lynn NHS Foundation Trust, Gayton Rd, King's Lynn, PE30 4ET, UK.
Hodson A; Department of Haematology, Ipswich Hospital, Ipswich Hospital NHS Trust, Heath Rd, Ipswich, IP4 5PD, UK.
Shah N; Department of Haematology, Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney Lane, Norwich, NR4 7UY, UK.
Sadullah S; Department of Haematology, James Paget University Hospital, James Paget University Hospitals NHS Foundation Trust, Lowestoft Road, Gorleston-on-Sea, Great Yarmouth, NR31 6LA, UK.
Grigoropoulos N; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Qian W; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Kirkwood AA; Cancer Research UK and University College London Cancer Trials Centre, University College London, 90 Tottenham Court Road, London, W1T 4TJ, UK.
Uttenthal BJ; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Johnson P; Cancer Research UK Centre, University of Southampton, University Road, Southampton, SO17 1BJ, UK.
Follows GA; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1049-1058. Date of Electronic Publication: 2021 Feb 27.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Hodgkin Disease/*drug therapy
Adolescent ; Adult ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Bleomycin/administration & dosage ; Clinical Trials as Topic/statistics & numerical data ; Combined Modality Therapy ; Cyclophosphamide/administration & dosage ; Dacarbazine/administration & dosage ; Doxorubicin/administration & dosage ; England/epidemiology ; Etoposide/administration & dosage ; Female ; Follow-Up Studies ; Hematopoietic Stem Cell Transplantation ; Hodgkin Disease/mortality ; Hodgkin Disease/therapy ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multicenter Studies as Topic/statistics & numerical data ; Prednisone/administration & dosage ; Pregnancy ; Pregnancy Complications, Neoplastic/drug therapy ; Pregnancy Complications, Neoplastic/epidemiology ; Procarbazine/administration & dosage ; Progression-Free Survival ; Retrospective Studies ; Treatment Outcome ; Vinblastine/administration & dosage ; Vincristine/administration & dosage ; Young Adult
SCR Protocol :
ABVD protocol; BEACOPP protocol
Czasopismo naukowe
Tytuł :
Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80-results from a single-center survey.
Autorzy :
Freudenberger F; Department of Internal Medicine III (Hematology, Oncology, Pneumology), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Ohler A; Department of Internal Medicine III (Hematology, Oncology, Pneumology), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Theobald M; Department of Internal Medicine III (Hematology, Oncology, Pneumology), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Hess G; Department of Internal Medicine III (Hematology, Oncology, Pneumology), University Medical Center of the Johannes Gutenberg University, Mainz, Germany. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1013-1021. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, Large B-Cell, Diffuse/*epidemiology
Age Factors ; Aged ; Aged, 80 and over ; Anthracyclines/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Combined Modality Therapy ; Cyclophosphamide/administration & dosage ; Doxorubicin/administration & dosage ; Female ; Humans ; Kaplan-Meier Estimate ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Large B-Cell, Diffuse/mortality ; Lymphoma, Large B-Cell, Diffuse/radiotherapy ; Male ; Prednisone/administration & dosage ; Prognosis ; Progression-Free Survival ; Radiotherapy, Adjuvant ; Rituximab/administration & dosage ; Treatment Outcome ; Vincristine/administration & dosage
SCR Protocol :
CHOP protocol
Czasopismo naukowe
Tytuł :
Dynamic evaluation of the prognostic value of F-FDG PET/CT in extranodal NK/T-cell lymphoma, nasal type.
Autorzy :
Xu P; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Guo R; Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
You J; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Cheng S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Li J; Clinical Research Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhong H; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Sun C; Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Xu H; Department of Radiation, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Huang H; School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Li B; Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Zhao W; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1039-1047. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Nasal Cavity*
Positron Emission Tomography Computed Tomography*
Lymphoma, Extranodal NK-T-Cell/*diagnostic imaging
Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Asparaginase/administration & dosage ; Dexamethasone/administration & dosage ; Etoposide/administration & dosage ; Female ; Fluorine Radioisotopes ; Fluorodeoxyglucose F18 ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Lymphoma, Extranodal NK-T-Cell/drug therapy ; Lymphoma, Extranodal NK-T-Cell/mortality ; Lymphoma, Extranodal NK-T-Cell/radiotherapy ; Male ; Methotrexate/administration & dosage ; Middle Aged ; Polyethylene Glycols/administration & dosage ; Prognosis ; Progression-Free Survival ; Proportional Hazards Models ; Prospective Studies ; Radiopharmaceuticals ; Radiotherapy, High-Energy ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma.
Autorzy :
Bernard S; Service d'hémato-Oncologie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), 1, Avenue Claude Vellefaux, 75010, Paris, France.
Hachon L; Service de Pharmacie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), F-75010, Paris, France.
Diasonama JF; Service d'hémato-Oncologie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), 1, Avenue Claude Vellefaux, 75010, Paris, France.
Madaoui C; Service de Pharmacie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), F-75010, Paris, France.
Aguinaga L; Service d'hémato-Oncologie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), 1, Avenue Claude Vellefaux, 75010, Paris, France.; Université de Paris, Paris Diderot, F-75010, Paris, France.
Miekoutima E; Service d'hémato-Oncologie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), 1, Avenue Claude Vellefaux, 75010, Paris, France.
Moatti H; Service d'hémato-Oncologie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), 1, Avenue Claude Vellefaux, 75010, Paris, France.; Université de Paris, Paris Diderot, F-75010, Paris, France.
Perrial E; INSERM 1052/CNRS 5286, F-69003, Lyon, France.
Madelaine I; Service de Pharmacie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), F-75010, Paris, France.
Brice P; Service d'hémato-Oncologie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), 1, Avenue Claude Vellefaux, 75010, Paris, France.
Thieblemont C; Service d'hémato-Oncologie, Assistance publique - Hôpitaux de Paris (AP-HP)- Hôpital Saint-Louis (SLS), 1, Avenue Claude Vellefaux, 75010, Paris, France. .; Université de Paris, Paris Diderot, F-75010, Paris, France. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 979-986. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article
MeSH Terms :
Antimetabolites, Antineoplastic/*therapeutic use
Central Nervous System/*pathology
Lymphoma, Large B-Cell, Diffuse/*drug therapy
Lymphoma, Non-Hodgkin/*drug therapy
Methotrexate/*therapeutic use
Adolescent ; Adult ; Ambulatory Care ; Antimetabolites, Antineoplastic/administration & dosage ; Antimetabolites, Antineoplastic/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Bleomycin/administration & dosage ; Chemical and Drug Induced Liver Injury/etiology ; Cyclophosphamide/administration & dosage ; Doxorubicin/administration & dosage ; Female ; Hematologic Diseases/chemically induced ; Humans ; Infusions, Intravenous ; Kidney Diseases/chemically induced ; Kidney Function Tests ; Leucovorin/therapeutic use ; Liver Function Tests ; Lymphoma, Large B-Cell, Diffuse/pathology ; Lymphoma, Non-Hodgkin/pathology ; Male ; Methotrexate/administration & dosage ; Methotrexate/adverse effects ; Middle Aged ; Neoplasm Invasiveness ; Outpatient Clinics, Hospital ; Prednisone/administration & dosage ; Retrospective Studies ; Rituximab/administration & dosage ; Vincristine/administration & dosage ; Vindesine/administration & dosage ; Young Adult
SCR Protocol :
CHOP protocol; LNH 87 protocol
Czasopismo naukowe
Tytuł :
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study.
Autorzy :
Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. .
Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Min CK; Seoul St. Mary's Hospital, Seoul, South Korea.
Kim K; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Yeh SP; China Medical University Hospital, Taichung, Taiwan.
Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
Mateos MV; University Hospital of Salamanca/IBSAL, Salamanca, Spain.
Nahi H; Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden.
Heuck C; Janssen Research & Development, LLC, Spring House, PA, USA.
Qin X; Janssen Research & Development, LLC, Raritan, NJ, USA.
Parasrampuria DA; Janssen Research & Development, LLC, Spring House, PA, USA.
Gries KS; Janssen Research & Development, LLC, Spring House, PA, USA.
Qi M; Janssen Research & Development, LLC, Spring House, PA, USA.
Bahlis N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
Ito S; Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Iwate, Japan.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1065-1077. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :
Clinical Trial, Phase III; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Salvage Therapy*
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
Asian Continental Ancestry Group/*statistics & numerical data
Multiple Myeloma/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/pharmacokinetics ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Agents, Immunological/pharmacokinetics ; Asian Continental Ancestry Group/psychology ; Body Weight ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Injections, Subcutaneous ; Japan/epidemiology ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multiple Myeloma/ethnology ; Multiple Myeloma/mortality ; Multiple Myeloma/therapy ; Neutropenia/chemically induced ; Patient Satisfaction ; Progression-Free Survival ; Republic of Korea/epidemiology ; Taiwan/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis.
Autorzy :
Modi D; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA. .
Singh V; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Kim S; Biostatistics Core, Karmanos Cancer Institute, Department of Oncology, Wayne State University, Detroit, MI, 48201, USA.
Ayash L; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Deol A; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Ratanatharathorn V; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Uberti JP; Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, HW04H0, Detroit, MI, 48201, USA.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 969-978. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Peripheral Blood Stem Cell Transplantation*
Antilymphocyte Serum/*therapeutic use
Busulfan/*therapeutic use
Graft vs Host Disease/*prevention & control
Immunosuppressive Agents/*therapeutic use
Leukemia, Myeloid, Acute/*therapy
Myeloablative Agonists/*therapeutic use
Transplantation Conditioning/*methods
Vidarabine/*analogs & derivatives
Aged ; Allografts ; Busulfan/adverse effects ; Female ; Graft vs Host Disease/etiology ; Humans ; Infections/epidemiology ; Lymphocyte Depletion ; Male ; Middle Aged ; Mycophenolic Acid/therapeutic use ; Myeloablative Agonists/adverse effects ; Progression-Free Survival ; Retrospective Studies ; T-Lymphocytes ; Tacrolimus/therapeutic use ; Treatment Outcome ; Unrelated Donors ; Vidarabine/adverse effects ; Vidarabine/therapeutic use ; Whole-Body Irradiation
Czasopismo naukowe
Tytuł :
Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis.
Autorzy :
Hu L; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Charwudzi A; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Li Q; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Zhu W; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Tao Q; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Xiong S; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China. .
Zhai Z; Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1003-1012. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Immunotherapy, Adoptive*
Salvage Therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Antigens, CD19/immunology ; Asian Continental Ancestry Group ; Disease-Free Survival ; Epidemiologic Studies ; European Continental Ancestry Group ; Humans ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/ethnology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Prognosis ; Recurrence ; Remission Induction ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Alpha thalassemia, but not β -globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort.
Autorzy :
Hatzlhofer BLD; Department of Pharmaceutical Sciences, Health Sciences Centre, Federal University of Pernambuco, Av. Prof. Arthur de Sá, s/n, Cidade Universitária, Recife, PE, 50740-521, Brazil. .; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil. .
Pereira-Martins DA; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.; Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
de Farias Domingos I; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.; Department of Clinical and Toxicological Analysis, Federal University of Rio Grande do Norte, Natal, Brazil.
Arcanjo GDS; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Weinhäuser I; Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Falcão DA; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Farias ICC; Biological Science Institute and College of Medical Sciences, University of Pernambuco, Recife, Brazil.
de Freitas Batista JVG; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Prado LPL; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Oliveira JMF; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Batista THC; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Sobreira MJVC; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
de Santana RM; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Araújo ABS; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
de Melo MA; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
de Ancântara BV; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Coelho-Silva JL; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.; Department of Medical Images, Hematology and, Clinical Oncology of The University of São Paulo, Ribeirão Preto Medical School, Ribeirão Preto, Brazil.
de Moura Rafael ABL; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
de Lima Silva DM; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Albuquerque FP; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.; Hematology and Hemotherapy Centre, State University of Campinas, Campinas, São Paulo, Brazil.
Santos MNN; Department of Clinical Pathology, School of Medical Sciences, State University of Campinas, Campinas, São Paulo, Brazil.
Dos Anjos AC; Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil.
Costa FF; Hematology and Hemotherapy Centre, State University of Campinas, Campinas, São Paulo, Brazil.
da Silva Araújo A; Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil.
Lucena-Araújo AR; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Bezerra MAC; Genetics Postgraduate Program, Centre of Biosciences, Federal University of Pernambuco, Recife, Brazil.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 921-931. Date of Electronic Publication: 2021 Feb 13.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Sickle Cell/*complications
alpha-Thalassemia/*complications
beta-Globins/*genetics
Adolescent ; Adult ; Aged ; Anemia, Sickle Cell/blood ; Anemia, Sickle Cell/genetics ; Arterial Occlusive Diseases/epidemiology ; Arterial Occlusive Diseases/etiology ; Brazil/epidemiology ; Child ; Cholelithiasis/epidemiology ; Cholelithiasis/etiology ; Female ; Fetal Hemoglobin/analysis ; Follow-Up Studies ; Haplotypes/genetics ; Hemolysis ; Humans ; Leg Ulcer/epidemiology ; Leg Ulcer/etiology ; Male ; Mutation ; Stroke/epidemiology ; Stroke/etiology ; Treatment Outcome ; Young Adult ; alpha-Thalassemia/blood ; alpha-Thalassemia/genetics
Czasopismo naukowe
Tytuł :
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration.
Autorzy :
Ruhe J; Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany. .
Gröne HJ; Department of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Schlosser M; Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
Kroegel C; Department of Internal Medicine I, Jena University Hospital, Jena, Germany.
Wolf G; Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
Busch M; Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1087-1088. Date of Electronic Publication: 2020 May 04.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
Autorzy :
González-Barca E; Lymphoma Unit, Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Av. Gran Via 199-203, 08908, Hospitalet de Llobregat, Barcelona, Spain. .
Capote FJ; Hematology, Hospital Puerta del Mar, Cádiz, Spain.
Gómez-Codina J; Onclology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Panizo C; Hematology, Clínica Universitaria de Navarra, Navarra, Spain.
Salar A; Hematology, Hospital del Mar, Barcelona, Spain.
Sancho JM; Hematology, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain.
López A; Hematology, Hospital de la Vall d'Hebron, Barcelona, Spain.
Briones J; Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Muñoz A; Oncology, Hospital Gregorio Marañón, Madrid, Spain.
Encuentra M; Clinical Trial Unit, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Barcelona, Spain.
Mercadal S; Lymphoma Unit, Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Av. Gran Via 199-203, 08908, Hospitalet de Llobregat, Barcelona, Spain.
Domingo-Domenech E; Lymphoma Unit, Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Av. Gran Via 199-203, 08908, Hospitalet de Llobregat, Barcelona, Spain.
de Sevilla AF; Lymphoma Unit, Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Av. Gran Via 199-203, 08908, Hospitalet de Llobregat, Barcelona, Spain.
Pokaż więcej
Corporate Authors :
GELTAMO (Spanish Lymphoma Group) and GOTEL (Group of Oncology for Therapy and Study of Lymphomas)
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1023-1029. Date of Electronic Publication: 2020 May 04.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Pragmatic Clinical Trial
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Lymphoproliferative Disorders/*drug therapy
Rituximab/*therapeutic use
Adult ; Aged ; Antineoplastic Agents/administration & dosage ; B-Lymphocytes/pathology ; Disease Progression ; Disease-Free Survival ; Epstein-Barr Virus Infections ; Female ; Follow-Up Studies ; Humans ; Immunosuppressive Agents/administration & dosage ; Kaplan-Meier Estimate ; Lymphoproliferative Disorders/etiology ; Male ; Middle Aged ; Organ Transplantation/adverse effects ; Prospective Studies ; Remission Induction ; Rituximab/administration & dosage ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies